Site Map

Home
Imprint, Site Map, Contact, Disclaimer
Technology
Laser microporation, Drug delivery, Applications, Publications, PharmaTelevision Interview with Christof Böhler
Products & Services
P.L.E.A.S.E.® Devices, Aesthetic dermatology, Medical solutions, Transdermal delivery, Intradermal delivery, Epidermal delivery, Infertility patches, Pipeline
Centres of Excellence
Massachusetts General Hospital / Harvard Medical School, USA, Bispebjerg Hospital Copenhagen, Denmark, Federal Teaching Hospital Feldkirch, Austria, University of Geneva, Switzerland, University of Salzburg, Austria, IVF centres Prof. Zech Bregenz, Austria
Partnering
Investors
About us
Company, The Big Picture, History, Management Team
Christof Böhler, PhD, CEO, Sven Rohmann, MD, PhD, Chief Business Officer, Thomas Bragagna, Chief Technology Officer, Norbert Clemens, MD, PhD, Clinical Director as permanent consultant
Board
Reinhard Braun, Chairman of the Board, Herbert Zech, Prof., MD, IVF-Specialist, Board Member, William D. Dearstyne, MBA, Board Member, Werner Braun, Mag. pharm., Pharmacist, Board Member, Michael Armbrüster, BSc, Board Member, Burkhard Feurstein, MSc, Board Member, Manfred Asamer, PhD, Board Member, Werner Lanthaler, PhD, Board Member, Christof Böhler, PhD, Chief Executive Officer
Advisory Board
Holger Lubatschowski, Prof. Dr. , R. Rox Anderson, Prof., MD, Robert Strohal, MD, Jean Luc Levy, MD, MBA, Yogeshvar N. Kalia, PhD
Career Opportunities, Contact, General terms and conditions
Events & News
Press releases
Press Articles
March 13, 2008, April 2, 2008, May, 2008, June 15, 2008, June 27, 2008, July, 2008, August, 2008, September, 2008, September, 2008, September, 2008, February, 2009, December, 2009, November, 2011
Archive
Human cutaneous tolerability study concluded positively, Nomination for Swiss Medtech Award 2007, New web animation showing how the P.L.E.A.S.E.® platform works, Pantec Biosolutions successfully initiates Series A Financing Round, Pantec Biosolutions presented new drug delivery platform and supporting preclinical data at Drug Delivery Partnerships 2008, Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform, Pantec Biosolutions appoints new Board members, Pantec Biosolutions receives ISO 13485 certification, Pantec Biosolutions Receives Marketing Clearance for P.L.E.A.S.E.®, Pantec Biosolutions Expands Scientific Advisory Board, Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E.® technology, Pantec Biosolutions Granted European Patent for P.L.E.A.S.E.®, Pantec Biosolutions is Granted SME Status in EU, Pantec Biosolutions reports successful Phase I for delivery of FSH using P.L.E.A.S.E.®, Pantec Biosolutions' P.L.E.A.S.E. Professional® Receives Marketing Authorisation, Pantec Biosolutions Closes CHF 20 Million Financing, Pantec Biosolutions receives "Honourable Mention" in red dot awards, Pantec Biosolutions to exhibit MEDICA 2010 World Forum in Düsseldorf, Germany on 17-20 November 2010, Pantec Biosolutions Achieves Clinical Efficacy POC for Delivery of urinary FSH using P.L.E.A.S.E.®, Pantec Biosolutions reports first successful IVF pregnancy using P.L.E.A.S.E.® -FSH patch
February 7, 2011, September 7, 2011, September 28, 2011, October 19, 2011, November 16, 2011, January 24, 2012, January 26, 2012
Conferences
16th annual DDP, , Medica 2011, Bio Europe 2011 - Download our Presentation, 20th EADV Congress, 20. Tagung der Deutschen Dermatologischen lasergesellscaft (DDL), Biopharm USA 2011 - Download our Presentation, Bio Europe Spring 2011, 15th Drug Delivery Partnerships
Disclaimer, Conference Presentations
Contact
Contact us
© Pantec Biosolutions AG, 2012. All rights reserved.